Clinical genetic testing adoption across China's extensive hospital network is approaching what many industry observers characterize as an inflection point in 2026, as oncology genomic profiling, reproductive genetic testing, rare disease genetic diagnosis, and pharmacogenomic testing transition from specialized academic medical center services to mainstream clinical tools deployed across...

The growing focus on preventive healthcare and early detection of inherited genetic disorders is significantly driving the demand for carrier testing services across North America. Advances in molecular diagnostics, increasing awareness regarding reproductive health, and the rapid adoption of precision medicine are transforming the genetic testing landscape. Healthcare providers and diagnostic...